Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine

Journal of Neurochemistry

Volumn 124, Issue 3, 2013, Pages 388-396

  Chai, Gao Shang ^a   Jiang, Xia ^a   Ni, Zhong Fei ^a   Ma, Zhi Wei ^a   Xie, Ao Ji ^a   Cheng, Xiang Shu ^a   Wang, Qun ^a   Wang, Jian Zhi ^a   Liu, Gong Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

amyloid; Alzheimer disease; betaine; homocysteine; synapse; tau

Indexed keywords

AMYLOID BETA PROTEIN; BETAINE; HOMOCYSTEINE; LEUCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; PHOSPHOPROTEIN PHOSPHATASE 2A; PRESENILIN 1; SYNAPSIN I; SYNAPTOTAGMIN; TAU PROTEIN; TYROSINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DEMETHYLATION; DENDRITIC CELL; DENDRITIC SPINE; DRUG EFFICACY; ENZYME ACTIVATION; HIPPOCAMPAL CA1 REGION; HYPERHOMOCYSTEINEMIA; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; MEMORY DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; SUPPLEMENTATION; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; BETAINE; DISEASE MODELS, ANIMAL; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; LIPOTROPIC AGENTS; MALE; MEMORY DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84872062676     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12094     Document Type: Article

References (59)

1. Abdelmalek M. F., Angulo P., Jorgensen R. A., Sylvestre P. B., and, Lindor K. D., (2001) Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am. J. Gastroenterol. 96, 2711-2717.
2. Alonso A. C., Grundke-Iqbal I., and, Iqbal K., (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783-787.
3. Avila J., Lim F., Moreno F., Belmonte C., and, Cuello A. C., (2002) Tau function and dysfunction in neurons: its role in neurodegenerative disorders. Mol. Neurobiol. 25, 213-231.
4. Barak A. J., Beckenhauer H. C., and, Tuma D. J., (1996) Betaine, ethanol, and the liver: a review. Alcohol 13, 395-398.
5. Best C. H., and, Channon H. J., (1935) The action of choline and other substances in the prevention and cure of fatty livers. Biochem. J. 29, 2651-2658.
6. Brattstrom L., Wilcken D. E., Ohrvik J., and, Brudin L., (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98, 2520-2526.
7. Bronstrup A., Hages M., Prinz-Langenohl R., and, Pietrzik K., (1998) Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. Am. J. Clin. Nutr. 68, 1104-1110.
8. Brouwer I. A., van Dusseldorp M., Thomas C. M., Duran M., Hautvast J. G., Eskes T. K., and, Steegers-Theunissen R. P., (1999) Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am. J. Clin. Nutr. 69, 99-104.
9. Busciglio J., Lorenzo A., and, Yankner B. A., (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.
10. Bussiere T., Giannakopoulos P., Bouras C., Perl D. P., Morrison J. H., and, Hof P. R., (2003) Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. J. Comp. Neurol. 463, 281-302.
11. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., and, Graham I., (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324, 1149-1155.
12. Clarke R., Smith A. D., Jobst K. A., Refsum H., Sutton L., and, Ueland P. M., (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55, 1449-1455.
13. Craig S. A., (2004) Betaine in human nutrition. Am. J. Clin. Nutr. 80, 539-549.
14. Deloughery T. G., Evans A., Sadeghi A., McWilliams J., Henner W. D., Taylor L. M. Jr, and, Press R. D., (1996) Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 94, 3074-3078.
15. Edbauer D., Winkler E., Regula J. T., Pesold B., Steiner H., and, Haass C., (2003) Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486-488.
16. Goedert M., (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16, 460-465.
17. Gonatas N. K., Stieber A., and, Gonatas J. O., (2006) Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J. Neurol. Sci. 246, 21-30.
18. Greengard P., Valtorta F., Czernik A. J., and, Benfenati F., (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259, 780-785.
19. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M., and, Binder L. I., (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913-4917.
20. Holm P. I., Hustad S., Ueland P. M., Vollset S. E., Grotmol T., and, Schneede J., (2007) Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677 C->t genotypes and B-vitamin status in a large-scale epidemiological study. J. Clin. Endocrinol. Metab. 92, 1535-1541.
21. Hooshmand B., Solomon A., Kareholt I., et al,. (2010) Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology 75, 1408-1414.
22. Jacques P. F., Bostom A. G., Williams R. R., Ellison R. C., Eckfeldt J. H., Rosenberg I. H., Selhub J., and, Rozen R., (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9.
23. Kharbanda K. K., Mailliard M. E., Baldwin C. R., Beckenhauer H. C., Sorrell M. F., and, Tuma D. J., (2007) Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J. Hepatol. 46, 314-321.
24. Kimberly W. T., and, Wolfe M. S., (2003) Identity and function of gamma-secretase. J. Neurosci. Res. 74, 353-360.
25. Knopman D., and, Patterson M., (2001) An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients. Alzheimer Dis. Assoc. Disord. 15, 162-165.
26. Kruman I. I., Culmsee C., Chan S. L., Kruman Y., Guo Z., Penix L., and, Mattson M. P., (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20, 6920-6926.
27. Lee V. M., Balin B. J., Otvos L. Jr, and, Trojanowski J. Q., (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675-678.
28. Lwin H., Yokoyama T., Date C., Yoshiike N., Kokubo Y., and, Tanaka H., (2002) Are the associations between life-style related factors and plasma total homocysteine concentration different according to polymorphism of 5,10-methylenetetrahydrofolate reductase gene (C677T MTHFR)? A cross-sectional study in a Japanese rural population. J. Epidemiol. 12, 126-135.
29. McCaddon A., Davies G., Hudson P., Tandy S., and, Cattell H., (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry. 13, 235-239.
30. McKinley M. C., McNulty H., McPartlin J., Strain J. J., Pentieva K., Ward M., Weir D. G., and, Scott J. M., (2001) Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am. J. Clin. Nutr. 73, 759-764.
31. Melse-Boonstra A., Holm P. I., Ueland P. M., Olthof M., Clarke R., and, Verhoef P., (2005) Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations. Am. J. Clin. Nutr. 81, 1378-1382.
32. Morris R., (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60.
33. Morrison L. M., (1952) Results of betaine treatment of atherosclerosis. Am. J. Dig. Dis. 19, 381-384.
34. Pacheco-Quinto J., Rodriguez de Turco E. B., DeRosa S., Howard A., Cruz-Sanchez F., Sambamurti K., Refolo L., Petanceska S., and, Pappolla M. A., (2006) Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol. Dis. 22, 651-656.
35. Pieribone V. A., Shupliakov O., Brodin L., Hilfiker-Rothenfluh S., Czernik A. J., and, Greengard P., (1995) Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375, 493-497.
36. Ramsden M., Kotilinek L., Forster C., et al,. (2005) Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 25, 10637-10647.
37. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., and, Licastro F., (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82, 636-643.
38. Richter-Levin G., and, Segal M., (1991) The effects of serotonin depletion and raphe grafts on hippocampal electrophysiology and behavior. J. Neurosci. 11, 1585-1596.
39. Rothenbacher D., Fischer H. G., Hoffmeister A., Hoffmann M. M., Marz W., Bode G., Rosenthal J., Koenig W., and, Brenner H., (2002) Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Atherosclerosis 162, 193-200.
40. Schwab U., Torronen A., Toppinen L., Alfthan G., Saarinen M., Aro A., and, Uusitupa M., (2002) Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am. J. Clin. Nutr. 76, 961-967.
41. Schwahn B. C., Hafner D., Hohlfeld T., Balkenhol N., Laryea M. D., and, Wendel U., (2003) Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br. J. Clin. Pharmacol. 55, 6-13.
42. Selhub J., (1999) Homocysteine metabolism. Annu. Rev. Nutr. 19, 217-246.
43. Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W., and, Wolf P. A., (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483.
44. Sisodia S. S., and, St George-Hyslop P. H., (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?. Nat. Rev. Neurosci. 3, 281-290.
45. Slutsky I., Abumaria N., Wu L. J., et al,. (2010) Enhancement of learning and memory by elevating brain magnesium. Neuron 65, 165-177.
46. Smith T. D., Adams M. M., Gallagher M., Morrison J. H., and, Rapp P. R., (2000) Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. J. Neurosci. 20, 6587-6593.
47. Soler J., Vinzia C., Gomez J. M., and, Morato J., (1984) Plafibride treatment of hyperlipidemias type II and IV. Med. Clin. 82, 840-842.
48. Steenge G. R., Verhoef P., and, Katan M. B., (2003) Betaine supplementation lowers plasma homocysteine in healthy men and women. J. Nutr. 133, 1291-1295.
49. Sun L., Liu S. Y., Zhou X. W., Wang X. C., Liu R., Wang Q., and, Wang J. Z., (2003) Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118, 1175-1182.
50. Sunden S. L., Renduchintala M. S., Park E. I., Miklasz S. D., and, Garrow T. A., (1997) Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch. Biochem. Biophys. 345, 171-174.
51. Terwel D., Lasrado R., Snauwaert J., Vandeweert E., Van Haesendonck C., Borghgraef P., and, Van Leuven F., (2005) Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J. Biol. Chem. 280, 3963-3973.
52. Tiraboschi P., Hansen L. A., Thal L. J., and, Corey-Bloom J., (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62, 1984-1989.
53. Ubbink J. B., Vermaak W. J., van der Merwe A., Becker P. J., Delport R., and, Potgieter H. C., (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124, 1927-1933.
54. Wilcken D. E., Wilcken B., Dudman N. P., and, Tyrrell P. A., (1983) Homocystinuria-the effects of betaine in the treatment of patients not responsive to pyridoxine. N. Engl. J. Med. 309, 448-453.
55. Wilcken D. E., Dudman N. P., and, Tyrrell P. A., (1985) Homocystinuria due to cystathionine beta-synthase deficiency-the effects of betaine treatment in pyridoxine-responsive patients. Metab. Clin. Exp. 34, 1115-1121.
56. Zeisel S. H., Mar M. H., Howe J. C., and, Holden J. M., (2003) Concentrations of choline-containing compounds and betaine in common foods. J. Nutr. 133, 1302-1307.
57. Zhang C. E., Tian Q., Wei W., Peng J. H., Liu G. P., Zhou X. W., Wang Q., Wang D. W., and, Wang J. Z., (2008) Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol. Aging 29, 1654-1665.
58. Zhang C. E., Wei W., Liu Y. H., Peng J. H., Tian Q., Liu G. P., Zhang Y., and, Wang J. Z., (2009) Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 174, 1481-1491.
59. Zhu L. Q., Wang S. H., Liu D., Yin Y. Y., Tian Q., Wang X. C., Wang Q., Chen J. G., and, Wang J. Z., (2007) Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J. Neurosci. 27, 12211-12220.